Balearics HIV tests target 400 undiagnosed cases

Around 400 people in the Balearic Islands are estimated to be living with HIV without knowing it. On 16 September, the Balearic health service IbSalut launched Focus, a programme adding HIV and hepatitis C tests to routine clinical care. The aim is to find infections earlier and get those diagnosed to specialist teams more quickly.

The scheme offers tests to people who are already having a blood test for any reason. This is known as opportunistic screening: a test can be offered even where there are no known risk factors, symptoms or particular medical condition.

Tests built into routine care

Focus is intended to become part of everyday medical practice step by step. Where possible, computer systems will identify patients who meet the set criteria during their care and make it easier for doctors to order the tests.

Where that cannot be automated, healthcare staff will receive training and support to help ensure the tests are routinely requested. IbSalut is working with Gilead Sciences, University Hospital Son Espases, Primary Care, the Centre for Care of Sexually Transmitted Infections (Caits), the Balearic Islands Health Research Institute (IdISBa) and Public Health.

Four-year plan to cut late diagnoses

The programme is planned for four years, with annual renewals. Gilead Sciences funds the screening, while IdISBa coordinates and manages the project alongside teams at Son Espases, Primary Care and Caits.

Focus has already been introduced in other regions. Since 2018, it has enabled more than 1.5 million tests for HIV and hepatitis B and C in Spain and Portugal. In the Balearic Islands, the goal is to reduce late diagnoses so follow-up and treatment can begin before health complications or deterioration develop.

Topics: Health

Source: Europa Press / Mallorca.com